David's coverage specializes in OTC medicines, dietary supplements and self-care medical devices. David is interested in regulatory gray areas such as the borderlines between medicines, supplements and medical devices, as well as botanical ingredients. David also regularly speaks to industry leaders and experts about the latest trends to deliver crucial market intelligence to HBW Insight readers, and co-hosts the Over the Counter podcast. In his spare time, David spends time in his allotment garden, reading/watching science fiction and worrying about climate change.
Latest from David Ridley
Pharmaceutical industry associations are united in their view that the revised EU Urban Wastewater Treatment Directive discriminates against medicines and cosmetics producers.
Kenvue's EMEA and LATAM head Carlton Lawson acknowledges the urgency of environmental issues like antimicrobial resistance and wastewater pollution in this interview with HBW Insight, but calls for a more balanced approach on the part of European regulators.
Kenvue backs UK government legislation proposing to remove access to nicotine products, including vapes, to under 18s and ban their advertising and sponsorship.
Kenvue's EMEA and LATAM head Carlton Lawson reflects on the firm's 18 months of independence, pointing to significant investments and operational improvements as key milestones on its spin out journey so far.
While the majority of British consumers don't want to pay more for eco-conscious products like foods and cosmetics, one in five would pay more for sustainable premium and luxury products and fast-moving consumer goods, reports Clear Channel.
Organizations representing APAC health and medicines regulators and the consumer health industry respectively have agreed to “recognize the importance of self-care as a fundamental pillar of health and wellbeing” and “affirm our dedication to advancing self-care as an essential component of Universal Health Coverage.”